Focus: Cleerly is an AI-driven medical imaging analytics company specializing in coronary artery disease assessment using computed tomography angiography (CCTA). The company operates as a software/diagnostic platform provider rather than a traditional drug manufacturer.
Profile data last refreshed 12h ago · AI intelligence enriched 2w ago
Hot — 41 jobs added in 30d
Net +32 (41 new, 9 removed). Aggressive expansion phase.
Best suited for AI engineers, data scientists, and diagnostic/imaging specialists seeking high-growth medtech exposure; less ideal for traditional pharma R&D or clinical development professionals.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Cleerly
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Cleerly's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo